| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 704886 | 2-Butenedioic acid, 2-[5-chloro-2,4-dioxo-3-(2-propynyl)-1H,3H-pyrimidinyl]-,diethyl ester, (2E)- | 0.0459335986102865 | -0.12689965 |
| NSC 706190 | 6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- | 0.0459335986102865 | -0.095541613 |
| NSC 726768 | 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline | 0.0459335986102865 | 0.047945217 |
| NSC 673421 | Null | 0.0459335986102869 | -0.20769649 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0459335986102872 | -0.33079788 |
| NSC 737613 | Null | 0.0459335986102872 | -0.23907244 |
| NSC 756166 | GSK312948A | 0.0459335986102872 | -0.19281707 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0459335986102872 | -0.39392305 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.0459335986102872 | -0.38154782 |
| NSC 102067 | 6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- | 0.0474314077111079 | 0.13231647 |